Literature DB >> 24829852

Magnetic resonance imaging in breast cancer: A literature review and future perspectives.

Gisela Lg Menezes1, Floor M Knuttel1, Bertine L Stehouwer1, Ruud M Pijnappel1, Maurice Aaj van den Bosch1.   

Abstract

Early detection and diagnosis of breast cancer are essential for successful treatment. Currently mammography and ultrasound are the basic imaging techniques for the detection and localization of breast tumors. The low sensitivity and specificity of these imaging tools resulted in a demand for new imaging modalities and breast magnetic resonance imaging (MRI) has become increasingly important in the detection and delineation of breast cancer in daily practice. However, the clinical benefits of the use of pre-operative MRI in women with newly diagnosed breast cancer is still a matter of debate. The main additional diagnostic value of MRI relies on specific situations such as detecting multifocal, multicentric or contralateral disease unrecognized on conventional assessment (particularly in patients diagnosed with invasive lobular carcinoma), assessing the response to neoadjuvant chemotherapy, detection of cancer in dense breast tissue, recognition of an occult primary breast cancer in patients presenting with cancer metastasis in axillary lymph nodes, among others. Nevertheless, the development of new MRI technologies such as diffusion-weighted imaging, proton spectroscopy and higher field strength 7.0 T imaging offer a new perspective in providing additional information in breast abnormalities. We conducted an expert literature review on the value of breast MRI in diagnosing and staging breast cancer, as well as the future potentials of new MRI technologies.

Entities:  

Keywords:  7.0 Tesla; Breast magnetic resonance imaging; Cancer; Diffusion-weighted imaging; Spectroscopy

Year:  2014        PMID: 24829852      PMCID: PMC4014797          DOI: 10.5306/wjco.v5.i2.61

Source DB:  PubMed          Journal:  World J Clin Oncol        ISSN: 2218-4333


  92 in total

1.  Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in Fatty and dense breasts using the whole-breast pathologic examination as a gold standard.

Authors:  Francesco Sardanelli; Gian M Giuseppetti; Pietro Panizza; Massimo Bazzocchi; Alfonso Fausto; Giovanni Simonetti; Vincenzo Lattanzio; Alessandro Del Maschio
Journal:  AJR Am J Roentgenol       Date:  2004-10       Impact factor: 3.959

Review 2.  Proton MRS of the breast in the clinical setting.

Authors:  Carolyn Mountford; Saadallah Ramadan; Peter Stanwell; Peter Malycha
Journal:  NMR Biomed       Date:  2009-01       Impact factor: 4.044

Review 3.  Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.

Authors:  Robert A Smith; Vilma Cokkinides; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2009 Jan-Feb       Impact factor: 508.702

4.  Predicting pathological response to neoadjuvant chemotherapy in breast cancer with quantitative 1H MR spectroscopy using the external standard method.

Authors:  Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Katsuya Maruyama; Eisuke Fukuma
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

5.  Impact of breast density on computer-aided detection for breast cancer.

Authors:  Rachel F Brem; Jeffrey W Hoffmeister; Jocelyn A Rapelyea; Gilat Zisman; Kevin Mohtashemi; Guarav Jindal; Martin P Disimio; Steven K Rogers
Journal:  AJR Am J Roentgenol       Date:  2005-02       Impact factor: 3.959

6.  Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival.

Authors:  P H Elkhuizen; M J van de Vijver; J Hermans; H M Zonderland; C J van de Velde; J W Leer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

7.  31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.

Authors:  Dennis W J Klomp; Bart L van de Bank; Alexander Raaijmakers; Mies A Korteweg; Cecilia Possanzini; Vincent O Boer; Cornelius A T van de Berg; Maurice A A J van de Bosch; Peter R Luijten
Journal:  NMR Biomed       Date:  2011-03-24       Impact factor: 4.044

8.  The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast.

Authors:  R M Mann; C E Loo; T Wobbes; P Bult; J O Barentsz; K G A Gilhuijs; C Boetes
Journal:  Breast Cancer Res Treat       Date:  2010-01       Impact factor: 4.872

9.  Contrast-enhanced MR imaging of breast lesions and effect on treatment.

Authors:  K Schelfout; M Van Goethem; E Kersschot; C Colpaert; A M Schelfhout; P Leyman; I Verslegers; I Biltjes; J Van Den Haute; J P Gillardin; W Tjalma; J C Van Der Auwera; P Buytaert; A De Schepper
Journal:  Eur J Surg Oncol       Date:  2004-06       Impact factor: 4.424

10.  Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent.

Authors:  C Boetes; R D Mus; R Holland; J O Barentsz; S P Strijk; T Wobbes; J H Hendriks; S H Ruys
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

View more
  34 in total

1.  Surgical attitudes toward preoperative breast magnetic resonance imaging in women with early-stage breast cancer.

Authors:  S D Mukherjee; N Hodgson; P J Lovrics; K Dhamanaskar; S Chambers; J Sussman
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

2.  Clinical utility of 18F-FDG-PET/MR for preoperative breast cancer staging.

Authors:  Diomidis Botsikas; Anastasia Kalovidouri; Minerva Becker; Michele Copercini; Dahila Amal Djema; Alexandre Bodmer; Sindy Monnier; Christoph D Becker; Xavier Montet; Benedicte M A Delattre; Osman Ratib; Valentina Garibotto; Claire Tabouret-Viaud
Journal:  Eur Radiol       Date:  2015-10-17       Impact factor: 5.315

3.  MRI sequences for the detection of individual lymph nodes in regional breast radiotherapy planning.

Authors:  Tristan C F van Heijst; Bram van Asselen; Ruud M Pijnappel; Marissa Cloos-van Balen; Jan J W Lagendijk; Desirée van den Bongard; Mariëlle E P Philippens
Journal:  Br J Radiol       Date:  2016-05-10       Impact factor: 3.039

4.  Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?

Authors:  Hale Aydin; Bahar Guner; Isil Esen Bostanci; Zarife Melda Bulut; Bilgin Kadri Aribas; Lutfi Dogan; Mehmet Ali Gulcelik
Journal:  Br J Radiol       Date:  2018-01-12       Impact factor: 3.039

5.  1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.

Authors:  Xin Wang; Xiang Jiang Wang; Hui Sheng Song; Long Hua Chen
Journal:  Med Oncol       Date:  2015-04-21       Impact factor: 3.064

6.  Cost-effectiveness of lung MRI in lung cancer screening.

Authors:  Bradley D Allen; Mark L Schiebler; Gregor Sommer; Hans-Ulrich Kauczor; Juergen Biederer; Timothy J Kruser; James C Carr; Gordon Hazen
Journal:  Eur Radiol       Date:  2019-11-20       Impact factor: 5.315

7.  A dual-tuned multichannel bilateral RF coil for 1 H/23 Na breast MRI at 7 T.

Authors:  Carlotta Ianniello; Guillaume Madelin; Linda Moy; Ryan Brown
Journal:  Magn Reson Med       Date:  2019-05-31       Impact factor: 4.668

Review 8.  Review of quantitative multiscale imaging of breast cancer.

Authors:  Michael A Pinkert; Lonie R Salkowski; Patricia J Keely; Timothy J Hall; Walter F Block; Kevin W Eliceiri
Journal:  J Med Imaging (Bellingham)       Date:  2018-01-22

9.  Radiomics methodology for breast cancer diagnosis using multiparametric magnetic resonance imaging.

Authors:  Qiyuan Hu; Heather M Whitney; Maryellen L Giger
Journal:  J Med Imaging (Bellingham)       Date:  2020-08-24

10.  Application of BI-RADS Descriptors in Contrast-Enhanced Dual-Energy Mammography: Comparison with MRI.

Authors:  Thomas Knogler; Peter Homolka; Mathias Hoernig; Robert Leithner; Georg Langs; Martin Waitzbauer; Katja Pinker; Sabine Leitner; Thomas H Helbich
Journal:  Breast Care (Basel)       Date:  2017-08-17       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.